Higher doses of laquinimod halted in trials
Higher doses of laquinimod halted in trials
Teva Pharmaceutical Industries and Active Biotech are to discontinue higher doses of their oral drug in development for multiple sclerosis in two trials, citing the occurrence of non-fatal cardiovascular events in eight patients...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/